These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 31467176)

  • 21. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects and mechanism of ensartinib (X-396) on the adhesion and metastasis of non-small cell lung cancer cells.
    Zhang B; Qiao T; Gao C
    Pharmazie; 2019 Sep; 74(9):543-546. PubMed ID: 31484594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Icotinib inhibits proliferation and epithelial-mesenchymal transition of non-small cell lung cancer A549 cells.
    Wang GH; Hu ZY
    Math Biosci Eng; 2019 Aug; 16(6):7707-7718. PubMed ID: 31698635
    [No Abstract]   [Full Text] [Related]  

  • 25. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.
    Cai F; Zhang Y; Li J; Huang S; Gao R
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non-small cell lung cancer.
    Li X; Fu Y; Xia X; Zhang X; Xiao K; Zhuang X; Zhang Y
    Cancer Med; 2019 Sep; 8(12):5750-5759. PubMed ID: 31397118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6-OH-BDE-47 promotes human lung cancer cells epithelial mesenchymal transition via the AKT/Snail signal pathway.
    Qu BL; Yu W; Huang YR; Cai BN; Du LH; Liu F
    Environ Toxicol Pharmacol; 2015 Jan; 39(1):271-9. PubMed ID: 25531265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
    De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
    J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
    Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
    Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
    Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
    Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diallyl disulphide suppresses the cannonical Wnt signaling pathway and reverses the fibronectin-induced epithelial mesenchymal transition of A549 lung cancer cells.
    Das B; Sinha D
    Food Funct; 2019 Jan; 10(1):191-202. PubMed ID: 30516195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
    Lee JH; Chinnathambi A; Alharbi SA; Shair OHM; Sethi G; Ahn KS
    Pharmacol Res; 2019 Dec; 150():104504. PubMed ID: 31678208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
    Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
    Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of Epithelial Mesenchymal Transition.
    Li B; Chen P; Wang JH; Li L; Gong JL; Yao H
    Microb Pathog; 2017 Nov; 112():171-175. PubMed ID: 28943152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.